TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request November 14, 1986
TCL Archive NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding. October 28, 2005
